These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5154114)

  • 1. [Chronic schizophrenia treated with depot perphenazine].
    Petersson H; Remvig J; Sorensen B
    Nord Psykiatr Tidsskr; 1971; 25(4):303-8. PubMed ID: 5154114
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R; Wegener G
    Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():7-10. PubMed ID: 3865501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of schizophrenics with perphenazine enanthate].
    Madsen A; Sorensen J
    Nord Psykiatr Tidsskr; 1971; 25(5):475-8. PubMed ID: 5144306
    [No Abstract]   [Full Text] [Related]  

  • 5. Depot perphenazine decanoate and enanthate for schizophrenia.
    Quraishi S; David A
    Cochrane Database Syst Rev; 2000; (2):CD001717. PubMed ID: 10796445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG; Dencker SJ; Gravem A; Remvig J
    Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in weight after treatment with depot neuroleptics.
    Korsgaard S; Skausig OB
    Acta Psychiatr Scand; 1979 Feb; 59(2):139-44. PubMed ID: 420033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of perphenazine and P-5227 in chronic schizophrenics: clinical and EEG effects.
    Holden JM; Itil TM; Keskiner A
    J Clin Pharmacol J New Drugs; 1969; 9(3):163-75. PubMed ID: 5255181
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent pharmacotherapy in chronic schizophrenia.
    Prien RF; Gillis RD; Caffey EM
    Hosp Community Psychiatry; 1973 May; 24(5):317-22. PubMed ID: 4574574
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of conventional neuroleptic therapy with depot neuroleptics. An attempt at economic evaluation.
    Lindholm H; Ljungberg L
    Acta Psychiatr Scand Suppl; 1973; 246():52-6. PubMed ID: 4520279
    [No Abstract]   [Full Text] [Related]  

  • 13. [Depot-neuroleptics in the treatment of schizophrenia].
    Schipper JA
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):707-9. PubMed ID: 5551427
    [No Abstract]   [Full Text] [Related]  

  • 14. Large variations of plasma levels during maintenance treatment with depot neuroleptics.
    Tuninger E; Levander S
    Br J Psychiatry; 1996 Nov; 169(5):618-21. PubMed ID: 8932892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perphenazine enanthate. Results of a 1-year open multicenter study].
    Baruch P; Brion S; Broussolle P; Gayral LF; Ropert R; Volmat R; Porot M
    Encephale; 1989; 15(5):449-55. PubMed ID: 2686965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of perphenazine and its sulfoxide during administration in oral and long-acting injectable form.
    van Kempen GM
    Psychopharmacologia; 1971; 21(3):283-6. PubMed ID: 5095416
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of an amitriptyline-perphenazine combination in chronic schizophrenia.
    Becker RE
    Am J Psychiatry; 1970 Dec; 127(6):827-31. PubMed ID: 4921622
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
    Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with depot neuroleptics.
    Bakke O
    Acta Psychiatr Scand Suppl; 1973; 246():32-4. PubMed ID: 4588180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with perphenazine enanthate].
    Rafter B
    Nord Psykiatr Tidsskr; 1971; 25(4):371-4. PubMed ID: 5154124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.